Clinical Nurse Specialist in Myeloma and Stem Cell Transplant

We have an exciting opportunity for an additional Band 7 Clinical Nurse Specialist to join our CNS team. The successful applicant should be an experienced Haemato-Oncology nurse with excellent communication skills and a good understanding of the Myeloma treatment pathway. The major element of the CNS role is to work as the patient's Key Worker to support, inform and coordinate the care of patients with Myeloma and Plasma Cell Disorders, including supporting the patient through Stem Cell Transplant.

The post holder will work in the Specialist Haemato-Oncology Team and will be well supported both by their CNS colleagues and wider MDT. CNSs work collaboratively with our Consultant colleagues who are keen to develop the team. There are 13 Haemato-Oncology CNS at SBH and they all work closely together to provide a wide range of specialist support including nurse led follow up and transplant coordination.

In the Barts Health Cancer Service there are lots of opportunities for learning and developing skills and we support nurses in their professional development.

Our Myeloma CNS team supports patients throughout their pathway from diagnosis to end of treatment. Treatments include, but not limited to, chemotherapy, mAbs, radiotherapy, bispecifics and stem cell transplantation. St Bartholomew's Hospital is a CAR-T centre., The post-holder will be responsible for the provision of specialist nursing care for patients with Myeloma and Plasma Cell Disorders, and their families from the point of diagnosis, throughout the patient pathway, including stem cell transplant, to end of life care. It is expected that the post holder is a clinical expert in Haemato-oncology care and can act as a resource for staff and an advocate for patients.

The post holder will work within the SBH Myeloma CNS team (3 WTE and 1 WTE Support Worker). This post may involve supporting a trainee CNS at times. This post is based at St Bartholomew's Hospital and liaises with the Haemato-Oncology CNSs based at referring hospitals. There are 13 Haemato-Oncology CNSs at SBH who share an office and work closely together.

It is expected that the post-holder attend the weekly Haemato-Oncology clinics, provide nurse led follow-up to autologous transplant patients and attend weekly MDT and transplant meetings.

The post holder will influence the positive experience of patients and carers living with Myeloma by working with the multi-disciplinary team across the Trust and acting as the patient's key worker.

Advance skills in communication, listening and recognizing physical and psychological side-effects are required to enable the post holder to advice, counsel and provide supportive care which will ensure best outcomes for patients with Myeloma and Plasma Cell Disorders.

Barts Health is one of the largest NHS trusts in the country, and one of Britain's leading healthcare providers.

The Barts Health group of NHS hospitals is entering an exciting new era on our improvement journey to becoming an outstanding organisation with a world-class clinical reputation. Having lifted ourselves out of special measures, we now have the impetus and breathing space to chart a fresh course in which we are continually striving to improve all our services for patients.

Our vision is to be a high-performing group of NHS hospitals, renowned for excellence and innovation, and providing safe and compassionate care to our patients in east London and beyond. That means being a provider of excellent patient safety, known for delivering consistently high standards of harm-free care and always caring for patients in the right place at the right time. It also means being an outstanding place to work, in which our WeCare values and behaviours are visible to all and guide us in how we work together.

We strive to live by our WeCare values and are committed to promoting inclusion, where every staff member has a sense of belonging. We value our differences and fully advocate, cultivate and support an inclusive working environment.